Grufity logo
Grufity logo
CMRA

CMRA - Comera Life Sciences Holdings, Inc. Stock Price, Fair Value and News

00
Market Closed as of 15 Jun 2026, 04:00 pm ET

Price Targets

00

CMRA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CMRA Price Action

CMRA RSI Chart

CMRA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CMRA Valuation

Market Cap

0

Price/Earnings (Trailing)

0

Price/Sales (Trailing)

0

Price/Free Cashflow

0

CMRA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

00

CMRA Fundamentals

CMRA Revenue

CMRA Earnings

CMRA Profitability

Free Cashflow Yield

0%

CMRA Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2023930.7K1.1M1.0M-
2022327.4K403.2K550.3K633.1K
2021-401.9K360.9K319.8K
2020---442.9K
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Comera Life Sciences Holdings, Inc.

CMRA
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
 CEO
 WEBSITEhttps://comeralifesciences.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES12

Comera Life Sciences Holdings, Inc. Frequently Asked Questions

CMRA is the stock ticker symbol of Comera Life Sciences Holdings, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu May 28 2026, market cap of Comera Life Sciences Holdings, Inc. is 0. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu May 28 2026, CMRA's PE ratio (Price to Earnings) is 0 and Price to Sales (PS) ratio is 0. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CMRA PE ratio will change depending on the future growth rate expectations of investors.